Use of COVID-19 Vaccines in the United States

Interim Clinical Considerations

Summary of recent changes (last updated July 20, 2022):
  • Guidance for primary series vaccination using Novavax COVID-19 Vaccine in adults ages 18 years and older
  • Updated guidance on COVID-19 vaccination and myocarditis and pericarditis
More about the Interim Clinical Considerations

See the FAQ page for answers to commonly asked questions about the Interim Clinical Considerations.

Page last reviewed: July 20, 2022